Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Bishop J.A.,,P40 (Î”Np63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma,2012,Modern Pathology,251,10.1038/modpathol.2011.173,United States,Article,Baltimore,1,Journal,2-s2.0-84857794792
Ju Y.,,A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing,2012,Genome Research,335,10.1101/gr.133645.111,South Korea;South Korea,Article,Seoul;Seoul,1,Journal,2-s2.0-84863230117
Rekhtman N.,,Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: Lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations,2012,Clinical Cancer Research,271,10.1158/1078-0432.CCR-11-2109,United States,Article,New York,1,Journal,2-s2.0-84857087591
Ciriello G.,,Mutual exclusivity analysis identifies oncogenic network modules,2012,Genome Research,368,10.1101/gr.125567.111,United States,Article,New York,1,Journal,2-s2.0-84856535081
Wang N.J.,,Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma,2011,Proceedings of the National Academy of Sciences of the United States of America,266,10.1073/pnas.1114669108,United States,Article,Berkeley,1,Journal,2-s2.0-80055092549
Bass A.,,Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion,2011,Nature Genetics,229,10.1038/ng.936,United States;United States;United States,Article,Boston;Boston;Cambridge,0,Journal,2-s2.0-80053385552
Reva B.,,Predicting the functional impact of protein mutations: Application to cancer genomics,2011,Nucleic Acids Research,942,10.1093/nar/gkr407,United States,Article,New York,1,Journal,2-s2.0-80053189298
Agrawal N.,,Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1,2011,Science,1112,10.1126/science.1206923,United States;United States,Article,Baltimore;Baltimore,0,Journal,2-s2.0-80052177544
Stransky N.,,The mutational landscape of head and neck squamous cell carcinoma,2011,Science,1512,10.1126/science.1208130,United States,Article,Cambridge,0,Journal,2-s2.0-80052158097
Felip E.,,"Metastatic non-small-cell lung cancer: Consensus on pathology and molecular tests, first-line, second-line, and third-line therapy 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010",2011,Annals of Oncology,107,10.1093/annonc/mdr150,Spain,Article,Barcelona,1,Journal,2-s2.0-79959703683
Bell D.,,Integrated genomic analyses of ovarian carcinoma,2011,Nature,4070,10.1038/nature10166,United States,Article,Rochester,1,Journal,2-s2.0-79959838081
Dutt A.,,Inhibitor-sensitive fgfr1 amplification in human non-small cell lung cancer,2011,PLoS ONE,302,10.1371/journal.pone.0020351,United States;India;United States,Article,Cambridge;Mumbai;Boston,1,Journal,2-s2.0-79958112619
Hammerman P.S.,,Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer,2011,Cancer Discovery,379,10.1158/2159-8274.CD-11-0005,United States,Article,Boston,1,Journal,2-s2.0-84866709500
Mermel C.,,GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers,2011,Genome Biology,1010,10.1186/gb-2011-12-4-r41,United States;United States,Article,Boston;Cambridge,1,Journal,2-s2.0-79955166265
Chapman M.A.,,Initial genome sequencing and analysis of multiple myeloma,2011,Nature,976,10.1038/nature09837,United Kingdom;United States,Article,Cambridge;Cambridge,1,Journal,2-s2.0-79951494668
Hanahan D.,,Hallmarks of cancer: The next generation,2011,Cell,30122,10.1016/j.cell.2011.02.013,United States;Switzerland,Review,San Francisco;Epalinges,1,Journal,2-s2.0-79952284127
Berger M.F.,,The genomic complexity of primary human prostate cancer,2011,Nature,859,10.1038/nature09744,United States;United States,Article,New York;Cambridge,1,Journal,2-s2.0-79951497419
Kancha R.,,The epidermal growth factor receptor-L861Q mutation increases kinase activity without leading to enhanced sensitivity toward epidermal growth factor receptor kinase inhibitors,2011,Journal of Thoracic Oncology,39,10.1097/JTO.0b013e3182021f3e,Germany,Article,Munich,1,Journal,2-s2.0-79551552012
Aster J.C.,,Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies,2011,Journal of Pathology,118,10.1002/path.2789,United States,Review,Boston,1,Journal,2-s2.0-78649991073
Weiss J.,,Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer,2010,Science Translational Medicine,608,10.1126/scitranslmed.3001451,Germany,Article,Koln,0,Journal,2-s2.0-78650451788
,,Proceedings from the 10th Annual Meeting of Molecularly Targeted Therapy in Non-small Cell Lung Cancer.,2010,Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,2,,,Conference Paper,,0,Journal,2-s2.0-79952460554
Singh A.,,Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance,2010,Antioxidants and Redox Signaling,119,10.1089/ars.2010.3219,United States,Article,Baltimore,0,Journal,2-s2.0-77958129306
Wilkerson M.,,"Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types",2010,Clinical Cancer Research,150,10.1158/1078-0432.CCR-10-0199,United States,Article,Chapel Hill,1,Journal,2-s2.0-77957570386
Kan Z.,,Diverse somatic mutation patterns and pathway alterations in human cancers,2010,Nature,724,10.1038/nature09208,United States,Article,San Francisco,0,Journal,2-s2.0-77955660663
Brahmer J.,,"Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: Safety, clinical activity, pharmacodynamics, and immunologic correlates",2010,Journal of Clinical Oncology,1811,10.1200/JCO.2009.26.7609,,Article,,0,Journal,2-s2.0-77954899030
Vaske C.,,Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM,2010,Bioinformatics,429,10.1093/bioinformatics/btq182,United States,Article,Santa Cruz,1,Journal,2-s2.0-77954195272
Beroukhim R.,,The landscape of somatic copy-number alteration across human cancers,2010,Nature,2144,10.1038/nature08822,United States;United States;United States;United States,Article,Cambridge;Boston;Boston;Boston,0,Journal,2-s2.0-77249119762
Stephens P.,,Complex landscapes of somatic rearrangement in human breast cancer genomes,2009,Nature,646,10.1038/nature08645,United Kingdom,Article,Hinxton,0,Journal,2-s2.0-72949119310
Shen R.,,Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis,2009,Bioinformatics,296,10.1093/bioinformatics/btp543,United States,Article,New York,1,Journal,2-s2.0-70449331456
Ramos A.H.,,Amplification of chromosomal segment 4q12 in non-small cell lung cancer,2009,Cancer Biology and Therapy,75,10.4161/cbt.8.21.9764,United States;United States;United States,Article,Boston;Boston;Cambridge,0,Journal,2-s2.0-73549108711
Bass A.J.,,SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas,2009,Nature Genetics,657,10.1038/ng.465,United States;United States;United States,Article,Boston;Boston;Cambridge,0,Journal,2-s2.0-70350641014
Ding L.,,Somatic mutations affect key pathways in lung adenocarcinoma,2008,Nature,1868,10.1038/nature07423,United States,Article,St. Louis,1,Journal,2-s2.0-54549094903
McLendon R.,,Comprehensive genomic characterization defines human glioblastoma genes and core pathways,2008,Nature,4803,10.1038/nature07385,United States,Article,Durham,1,Journal,2-s2.0-54549108740
Shibata T.,,Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy,2008,Proceedings of the National Academy of Sciences of the United States of America,478,10.1073/pnas.0806268105,Japan,Article,Chuo-ku,1,Journal,2-s2.0-51649130168
Kenfield S.,,Comparison of aspects of smoking among the four histological types of lung cancer,2008,Tobacco Control,128,10.1136/tc.2007.022582,United States;United States;United States,Article,Boston;Boston;Boston,0,Journal,2-s2.0-45349086437
Soda M.,,Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer,2007,Nature,3648,10.1038/nature05945,Japan,Article,Kawachi District,0,Journal,2-s2.0-34547638047
Singh A.,,Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer,2006,PLoS Medicine,682,10.1371/journal.pmed.0030420,United States,Article,Baltimore,1,Journal,2-s2.0-33750885385
Wikman H.,,Regulation of the G<inf>1</inf>/S phase of the cell cycle and alterations in the RB pathway in human lung cancer,2006,Expert Review of Anticancer Therapy,52,10.1586/14737140.6.4.515,Germany,Review,Hamburg,0,Journal,2-s2.0-33746270787
Osada H.,,ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine features,2005,Cancer Research,90,10.1158/0008-5472.CAN-05-1404,Japan,Article,Nagoya,1,Journal,2-s2.0-28244448285
Tonon G.,,High-resolution genomic profiles of human lung cancer,2005,Proceedings of the National Academy of Sciences of the United States of America,313,10.1073/pnas.0504126102,United States,Article,Boston,1,Journal,2-s2.0-22144433675
Pao W.,,"EGF receptor gene mutations are common in lung cancers from ""never smokers"" and are associated with sensitivity of tumors to gefitinib and erlotinib",2004,Proceedings of the National Academy of Sciences of the United States of America,3618,10.1073/pnas.0405220101,United States,Article,New York,1,Journal,2-s2.0-4444344330
Paez J.G.,,"EGFR mutations in lung, cancer: Correlation with clinical response to gefitinib therapy",2004,Science,7753,10.1126/science.1099314,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-2342624080
Lynch T.,,Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib,2004,New England Journal of Medicine,9168,10.1056/NEJMoa040938,United States,Article,Boston,0,Journal,2-s2.0-2342471392
Massion P.P.,,Significance of p63 Amplification and Overexpression in Lung Cancer Development and Prognosis,2003,Cancer Research,257,,United States;United States,Article,Nashville;Nashville,0,Journal,2-s2.0-10744221856
